Groundbreaking Malaria Vaccine under Test
Why in news?
- The World Health Organisation welcomed a pilot project in Malawi of administering a malaria vaccine to children below the age of 2 years. A total 3,60,000 children across three African countries — Malawi, Ghana and Kenya — will be covered every year with the vaccine.
What is the RTS, S (Mosquirix) vaccine?
- RTS, S/AS01 (trade name Mosquirix) is a recombinant protein-based malaria vaccine.
- A pilot project for vaccination has been launched on April 23, 2019 in Malawi. Ghana and Kenya are to join the program later this year.
- The vaccine has been developed by GSK (GlaxoSmithKline ) ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 Three Years of NLP Transforming India’s Supply Chain Ecosystem
- 2 Promotion and Regulation of Online Gaming in India
- 3 UNGA 80: Rebuilding Trust and Reforming the Global Order
- 4 India’s Obesity Epidemic: A Growing Public Health Challenge
- 5 Tech-Driven Resilience: Modern Tools for Disaster Management
- 6 Saudi-Pakistan Defence Pact: Implications for India
- 7 Hydrogen-Powered Transport: A Pillar of Green Growth
- 8 From Harvest to Home: Building Resilient Infrastructure for Storage of Food Grains
- 9 Strategic Mineral Mining Projects Exempted from Public Hearing
- 10 River Rejuvenation Projects in India: Challenges & Imperatives

